RE: Sierra - March Public Offerering ?23 Sep 2020 10:21
FWIW (Which is not a lot) my view is that: I agree with Thoth2 etc that the Science is the foundation on which the company (house) is built, and the science is great (at the moment), having great foundations is great in itself, a big pharma may see the potential and buy it I also agree with brighty, Aber, Nicksmith (etc) that PR is the key. The house may be solid but it needs carpets, decorating, garden designed and kept well manicured, make the finishing top spec. Make it desirable to buyers. This bit is called PR. To maximise the saleability and the price both are vital to keeping SAR on big pharma's (and Institutional Investors) interested and wanting to buy. This creates a market, thus pushing the price up. It is incredibly frustrating. We've lost control of 737 and we've lost control of flt3. SAR do not have a good track record of decision making when it comes to deal making. To use another analogy: I may be brilliant at building houses, but a sh*t decorator. Is my house going to be more desirable than the one next door, where the house is sh*t but the decorators amazing. At best mine would be seen as a doer upper and would not be worth top dollar. It's so frustrating!!!! But as usual I can see the SP dropping possibly to .68/.70 region before gaining 30% back to the low / mid .90's, the slow slide back to .68/.70 then repeat until somebody buys us. (Which they will). The question is how much will be sell for? Will we get top dollar or will be bought as a doer upper. Either way upside is massive, it's just the wait for a buyer that's frustrating. (AIMHO DYOR)